Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01506440 · ClinicalTrials.gov registry record
Cognitive Assessments in Patients With Cancer Undergoing Chemotherapy
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 29
- Enrollment target
NCT01506440: Completed study, sponsored by Wake Forest University Health Sciences.
NCT01506440 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 29 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01506440 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 29 participants
- Enrollment target
Study Summary
This pilot clinical trial studies cognitive assessments in patients with cancer undergoing chemotherapy. Questionnaires that measure cognitive changes during chemotherapy may help identify the side effects of chemotherapy.
Primary Outcome
To determine whether cognitive assessment tools can be administered within the clinical and scheduling constraints of current chemotherapy administration practices.
Interventions
- PROCEDURE quality-of-life assessment
- PROCEDURE cognitive assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2011-10 |
| Est. Completion | 2012-10 |
What the finished NCT01506440 record still lists
NCT01506440 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 29 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which quality-of-life assessment is the first listed.
NCT01506440 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01506440 about?
NCT01506440 is a clinical study titled "Cognitive Assessments in Patients With Cancer Undergoing Chemotherapy". This pilot clinical trial studies cognitive assessments in patients with cancer undergoing chemotherapy. Questionnaires that measure cognitive changes during chemotherapy may help identify the side effects of chemotherapy.
What is the current status of trial NCT01506440?
This trial is currently completed. The enrollment target is 29 participants. The study started on 2011-10. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01506440?
The interventions under investigation include: quality-of-life assessment (PROCEDURE), cognitive assessment (PROCEDURE).
Who is sponsoring clinical trial NCT01506440?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia